Protein Production
The catalytic domain of human PHD2 181-426 (tPHD2) was produced and purified as reported. 1 tPHD2 was used for all experiments, unless otherwise stated. °C. Protein purification was as reported. 3, 4 Apo-PHD2 was prepared by incubating tPHD2 or PHD2 181-402 (2-3 mg/mL) with 15,000-equivalents of EDTA at 4 ºC overnight. The treated proteins were further purified using a Superdex S200 column (300 mL). The purity of the resulting fractions was ascertained to be > 90 % by SDS-PAGE. Removal of the metal was confirmed by non-denaturing mass spectrometry and activity analyses.
Non-Denaturing MS Experiments
For non-denaturing MS measurements, spectra were obtained using a Data were processed using MASSLYNX 4.0 (Waters). 5 
Fluorescence Polarisation Assay
Fluorescence polarisation 7 
Isothermal Titration Calorimetry Experiments
Isothermal titration calorimetry (ITC) experiments were performed using a Malvern established by 1 H NMR with an internal standard. In the experiments using tPHD2.Zn.2OG, to preclude the possibility of protein degradation giving a negative result, the same sample of protein used for both experiments and the titration using HyCODD was run before the titration with CODD.
NMR Experiments
Nuclear Magnetic Resonance (NMR) spectra were recorded using a Bruker AVIII 700
MHz NMR spectrometer equipped with a 5-mm inverse cryoprobe using 5 mm diameter NMR tubes (Norell) or 3 mm MATCH NMR tubes (Cortectnet). Data were processed with Bruker 3.1 software. 
CPMG-edited 1 H NMR Experiments

C-2OG and C-NODD/CODD Displacement Experiments
The CLIP-HSQC sequence was used for 1D 13 C HSQC experiments (without 13 C decoupling). 12 The relaxation delay was 2 s and the 1 J CH was set to 160 Hz. A 6.8 ms Q3 180-degree pulse was used for selective 13 14 and a modelled collagen triple helix (C4-endo Hyp) (PDB: 3B2C) 15 complexes as templates using COOT. 16 All models were conjugate energy minimized to ensure their geometric quality without applying any external energy term.
Computational Studies
MD Simulation Studies
Two structures of tPHD2.Mn.CODD were studied; one with Hyp564 in the C4 cis conformation and one with Hyp564 in the C4 trans conformation. For each conformation, two different co-substrate/product binding modes were considered, i.e. bidentate binding with 2-oxoglutarate (2OG) and monodentate binding with succinate. In total, four systems were prepared, as indicated in Table S1 . The protein was solvated using the Solvate plug-in of VMD, 17 resulting in a box size of (82x82x82) Å 3 . The system was ionised to be electrically neutral using a 0.15 mM background ionic concentration of NaCl. Protonation states were chosen corresponding to pH 7.0, with δ-His313 and δ-His374 protonation states in the active site.
For each system, we first tested the validity of the initial PDB derived model of tPHD2, using a substrate conformation obtained based on semi-automated (knowledge-based)
docking. The initial MD simulation system setup was based on the structure of tPHD2.Mn.CODD.2OG 11 with Mn(II) exchanged for Fe(II). The MD simulation (10 ns) was performed for the initial modelled complex with backbone restraints of tPHD2 chain A, as well as the active site residues H313, D315, H374, 2OG or succinate, Fe(II) replacing the Mn(II) density, and H564 from the substrate peptide. Following this, MD production runs in the NPT ensemble were performed for 40 ns for each system, totalling 200 ns, keeping only the active site restrained, using a system temperature of 300 K and 1 bar pressure.
The protein conformation was simulated using the CHARMM 36 force-field (FF), with the CMAP correction; 18 a TIP3P water model was employed. 19 CHARMM FF parameters for the 2OG ligand compatible with version 2b7 of the CHARMM General ForceField (CGenFF) [20] [21] [22] [23] were generated and validated using the Force-Field toolkit plugin in VMD, 24 after initial atom typing and assignment of parameters and charges using version 0.9.7 of the CGenFF program at paramchem.org. 21, 23 
QM/MM Studies
Using the MD simulation system setups, we performed quantum mechanics/molecular mechanics (QM/MM) geometry optimisation using the CP2K code 25 (http://cp2k.berlios.de).
Details of the systems studied are summarized in Table S1 . The interaction energy for the QM region was computed via the QuickStep module within CP2K, 26, 27 with the FIST MM driver, and using a real-space multigrid technique for the electrostatic coupling between the QM and MM regions. 28, 29 The QM region was treated using density functional theory (DFT) with the BLYP exchange correlation energy functional 30, 31 employing the GTH pseudopotential of Goedecker et al., 32, 33 and double-zeta valence plus polarisation (DZVP) basis sets (optimised for BLYP) as implemented in CP2K. The Fe(II) metallocenter was described using the DZVP basis sets optimised for BLYP. The plane wave was expanded up to a density cut-off of 300 Ry. For the MM region, the CHARMM 36 force-field49 was used with the TIP3P water model, via the FIST module within CP2K to calculate the MM interaction energy. Interactions between the QM and MM regions were calculated using the procedure of Laino et al. 28 MM and QM optimisations were performed separately, with the QM/MM interface described with the IMOMM link-atom method, 34 where positions of hydrogen capping atoms were expressed as a function of the coordinates of atoms forming the original bond, and the forces on the link atoms were accordingly redistributed. A scaling factor of 1.38 was applied to relate the MM carbon-carbon distances to the QM carbonhydrogen ones. Only succinate/2OG, D315, Fe(II), and Hyp564 was included in the QM region; the rest of the protein was treated at the MM level. The total charge of the QM region in each system is summarised in Table S2 . Geometry optimisations were performed up to 200
iterations. For every step, the electronic structure was explicitly quenched to a tolerance of 10 -14 hartree, and a convergence criteria of 10 -3 for the RMS force and gradient was employed. Fig. S1 . (Fig. S5) . The assay conditions are given in the Materials and Methods. (Fig. 2 and S6) . Supplementary Tables   Table S1. Summary of 
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N-terminally fluorescein isothiocyanate (FITC)-labelled
HIF-1α CODD peptide; CODD*). After determining the best conditions for the tracer, competitive binding assays were conducted by titrating increasing concentrations of competing ligands to a fixed (optimal) tracer and tPHD2 concentrations
